Earnings Preview: Pfizer (PFE)

Pfizer PFE is set to report earnings tomorrow before the bell, and Wall Street will be looking to see how expiring drugs are going to affect the company's earnings going forward, as well as any more clarity on the breakup of the company. At last check, shares of Pfizer were up 7 cents to $21.04, a gain of 0.33%‎ on 24 million shares today. The company has a 3.8% dividend yield, and trades at 9.8 times 2012 earnings. Wall Street is looking for earnings of 59 cents per share on revenues of $16.65 billion, down 0.5% from last year, when it reported earnings of 60 cents per share on revenues of $16.74 billion. Guidance for next quarter is expected to come in at 59 cents per share on $17.07 billion in revenues.